Full name
"PHARMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
41.20.Z - Construction work related to the construction of residential and non-residential buildings
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
82.19.Z - Office administrative support activities and other business support services
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 1,4 | 1,8 | 28,3 |
EBITDA | 1,1 | 1,4 | 1,6 | 15,8 |
Short time liabilities | 2,3 | 1,5 | 1,2 | -21,4 |
Equity capital | 8,5 | 9,9 | 10,3 | 4,4 |
Operating profit (EBIT) | 1 | 1,3 | 1,6 | 20,9 |
Assets | 10,8 | 11,4 | 11,5 | 1 |
Net profit (loss) | 0,9 | 1,4 | 1,6 | 15,4 |
Cash | 5,6 | 4,4 | 4,3 | -1,6 |
Net income from sale | 20,9 | 25 | 26,8 | 7,1 |
Liabilities and provisions for liabilities | 2,3 | 1,5 | 1,2 | -21,4 |
Working assets | 7,9 | 7,4 | 7,1 | -3,7 |
Depreciation | 0,1 | 0,1 | 0 | -52,5 |
% | % | % | p.p. | |
Profitability of capital | 14,1 | |||
Equity capital to total assets | 78,9 | 86,7 | 89,6 | 2,9 |
Gross profit margin | 5 | 5,5 | 6,6 | 1,1 |
EBITDA Margin | 5,3 | 5,6 | 6 | 0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 12 | |||
Current financial liquidity indicator | 3.4895682334899902 | 4.8899359703063965 | 5.991866111755371 | 1,1 |
Net dept to EBITDA | -1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane